etoposide has been researched along with anisomycin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Choi, EJ; Han, PL; Kim, I; Lee, K; Oh, YJ; Park, J | 1 |
| Bouchard, D; del Barco Barrantes, I; Duncan, GS; Elia, A; Mak, TW; Millar, DG; Nguyen, L; Ohashi, PS; Plyte, S; Ruland, J; Wakeham, A | 1 |
| Augery-Bourget, Y; Poindessous-Jazat, V; Robert-Lézénès, J | 1 |
| Maag, RS; Machamer, CE; Mancini, M; Rosen, A | 1 |
| Chang, NS; Doherty, J; Ensign, A; Hong, Q; Hsu, LJ; Schultz, L | 1 |
| Abayasiriwardana, KS; Barbone, D; Broaddus, VC; Dansen, TB; Evan, GI; Hunt, AE; Kim, KU; Lee, KK; Vivo, C | 1 |
| Koike, A; Koike, M; Ninomiya, Y | 1 |
| Lee, SW; Liou, YC; Ongusaha, P; Xia, Y | 1 |
| Cao, J; Cao, M; Du, L; Feng, J; Jin, J; Li, X; Liang, S; Shen, B; Wang, H; Wang, J; Yu, J; Zhang, J; Zhang, Y; Zhou, Y; Zhu, T | 1 |
11 other study(ies) available for etoposide and anisomycin
| Article | Year |
|---|---|
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Activation of c-Jun N-terminal kinase antagonizes an anti-apoptotic action of Bcl-2.
Topics: Animals; Anisomycin; Antineoplastic Agents, Phytogenic; Apoptosis; Calcium-Calmodulin-Dependent Protein Kinases; Carcinogens; DNA Fragmentation; Enzyme Activation; Etoposide; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-bcl-2; Staurosporine; Transfection; Tumor Cells, Cultured; Ultraviolet Rays | 1997 |
Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure.
Topics: Adaptor Proteins, Signal Transducing; Animals; Anisomycin; Antibody Formation; Antineoplastic Agents; Apoptosis; B-Cell CLL-Lymphoma 10 Protein; B-Lymphocytes; Cell Division; Central Nervous System; Cisplatin; Enzyme Inhibitors; Etoposide; Genes, Lethal; Immunity, Cellular; Lymphocyte Activation; Mice; Mice, Knockout; Neoplasm Proteins; Neural Tube Defects; NF-kappa B; Nucleic Acid Synthesis Inhibitors; Protein Synthesis Inhibitors; Receptors, Antigen; Signal Transduction; Staurosporine; T-Lymphocytes | 2001 |
C-Jun modulates apoptosis but not terminal cell differentiation in murine erythroleukemia cells.
Topics: Animals; Anisomycin; Antibiotics, Antineoplastic; Apoptosis; Cell Differentiation; Culture Media, Serum-Free; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Daunorubicin; Dimethyl Sulfoxide; DNA, Antisense; Enzyme Activation; Enzyme Inhibitors; Etoposide; Gene Expression Regulation, Leukemic; Genes, jun; JNK Mitogen-Activated Protein Kinases; Leukemia, Erythroblastic, Acute; Mice; Mitogen-Activated Protein Kinases; Neoplasm Proteins; Phosphorylation; Protein Processing, Post-Translational; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-jun; Recombinant Fusion Proteins; Topoisomerase II Inhibitors; Transfection; Tumor Cells, Cultured | 2002 |
Caspase-resistant Golgin-160 disrupts apoptosis induced by secretory pathway stress and ligation of death receptors.
Topics: Anisomycin; Apoptosis; Apoptosis Regulatory Proteins; Autoantigens; Caspases; Enzyme Inhibitors; Etoposide; Fluorescent Antibody Technique, Indirect; Golgi Matrix Proteins; Green Fluorescent Proteins; HeLa Cells; Humans; Kinetics; Membrane Glycoproteins; Membrane Proteins; Microscopy, Fluorescence; Mutation; Nucleic Acid Synthesis Inhibitors; Precipitin Tests; Staurosporine; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha | 2005 |
WOX1 is essential for tumor necrosis factor-, UV light-, staurosporine-, and p53-mediated cell death, and its tyrosine 33-phosphorylated form binds and stabilizes serine 46-phosphorylated p53.
Topics: Active Transport, Cell Nucleus; Animals; Anisomycin; Cell Line, Tumor; Cell Nucleus; Cytoplasm; Cytosol; DNA, Complementary; Dose-Response Relationship, Drug; Etoposide; Fibroblasts; Genes, Dominant; Humans; Hypoxia; Imidazoles; Immunoprecipitation; Luminescent Proteins; Mice; Microscopy, Fluorescence; Models, Biological; Oxidoreductases; Phosphorylation; Piperazines; Proteasome Endopeptidase Complex; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serine; Staurosporine; Time Factors; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Two-Hybrid System Techniques; Tyrosine; U937 Cells; Ultraviolet Rays; WW Domain-Containing Oxidoreductase | 2005 |
Malignant mesothelioma cells are rapidly sensitized to TRAIL-induced apoptosis by low-dose anisomycin via Bim.
Topics: Anisomycin; Annexin A5; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Combined Modality Therapy; Cycloheximide; Drug Synergism; Electrophoresis, Gel, Two-Dimensional; Etoposide; Humans; Immunoblotting; JNK Mitogen-Activated Protein Kinases; Ligands; Membrane Proteins; Mesothelioma; Phosphorylation; Protein Synthesis Inhibitors; Proto-Oncogene Proteins; RNA, Small Interfering; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured | 2007 |
Characterization of Ninjurin and TSC22 induction after X-irradiation of normal human skin cells.
Topics: Anisomycin; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Northern; Cell Adhesion Molecules, Neuronal; Cell Cycle Proteins; Cell Line; Dose-Response Relationship, Radiation; Etoposide; Gene Expression Profiling; Gene Expression Regulation; Humans; Keratinocytes; Nerve Growth Factors; Oligonucleotide Array Sequence Analysis; Plasmids; Repressor Proteins; RNA, Messenger; Transfection | 2008 |
Loss of Wip1 sensitizes cells to stress- and DNA damage-induced apoptosis.
Topics: Animals; Anisomycin; Antineoplastic Agents, Phytogenic; Apoptosis; Cells, Cultured; DNA Damage; Embryo, Mammalian; Enzyme Inhibitors; Etoposide; Fas Ligand Protein; Fibroblasts; Hydrogen Peroxide; Immunoblotting; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase Kinases; Mice; Mice, Knockout; Nucleic Acid Synthesis Inhibitors; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphoprotein Phosphatases; Phosphorylation; Protein Phosphatase 2C; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-jun; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Staurosporine; Tumor Suppressor Protein p53; Ultraviolet Rays | 2009 |
Components of the JNK-MAPK pathway play distinct roles in hepatocellular carcinoma.
Topics: Anisomycin; Apoptosis; Carcinoma, Hepatocellular; Etoposide; Humans; JNK Mitogen-Activated Protein Kinases; Liver Neoplasms; MAP Kinase Kinase 7; Tumor Necrosis Factor-alpha | 2023 |